Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Class A Common Shares
-
Shares outstanding
-
98,656,192
-
Total 13F shares
-
243,504
-
Share change
-
+33,034
-
Total reported value
-
$577,000
-
Price per share
-
$2.37
-
Number of holders
-
1
-
Value change
-
+$78,277
-
Number of buys
-
1
Institutional Holders of Cardiol Therapeutics Inc. - Class A Common Shares (CRDL) as of Q2 2020
As of 30 Jun 2020,
Cardiol Therapeutics Inc. - Class A Common Shares (CRDL) was held by
1 institutional
shareholder
that filed Form 13F with the SEC.
Together, they reported ownership of
243,504 shares.
The largest 1 holders included
AdvisorShares Investments LLC.
This page lists
1
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.